It’s no easy gig analysing share prices and company performance but somebody’s got to do it. Two experts give us their recommendations.
Australia's richest person has placed a $125m bet on rare earths despite market volatility, showing long-term confidence in ...
Gina Rinehart's Hancock Prospecting made more than $3bn profit in FY25, and fired missives at the Federal Government's Net ...
Blue Star Helium (ASX:BNL) has started construction at its Galactica helium project in Colorado, marking a major step toward ...
Mark Creasy's CZR has $76 million burning a hole in its back pocket, and it has major gold and copper discoveries on the agenda.
ELM Responsible Investments focuses on sustainable stocks there for the long term, but don't presume they are ESG ...
Well, at least it wasn’t a total market massacre today – gold revived just in time to offset Mayne Pharma’s Halloween shocker ...
Scott Power (actually Iain Wilkie): CSL’s fall haunts ASX healthcare, but Morgans sees opportunities
The ASX healthcare sector has felt the fallout this week of CSL's latest selloff after management trimmed FY26 guidance at ...
Figures from the World Gold Council have confirmed what we've all suspected, that gold demand hit a record high in the ...
Gold and rare earths lit up a gloomy Halloween session as small caps clawed their way higher despite global market chills.
ASX companies are progressing their Latin American assets as US demand for critical minerals continues to grow to secure ...
Imagion Biosystems, Singular Health and Audeara were among ASX health companies reporting quarterly results this week.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results